ShanghaiJune 3, 2026 /PRNewswire/ — On June 1, 2026 (EDT) during ASMS, SCIEX, an operating company of Danaher Corporation and a global innovator in life science analysis technology, officially launched the novus V55 mass spectrometer. This is a next-generation triple quadrupole mass spectrometry platform designed for high-intensity, results-oriented laboratories.
novus V55 mass spectrometer
The novus V55 is centered on exceptional sensitivity and accelerated output, while achieving a smaller footprint and superior energy efficiency. It helps modern laboratories achieve higher efficiency under resource constraints, further expanding detection capabilities in diverse application scenarios such as pesticide residue and food analysis, pharmaceutical impurity analysis, bioanalysis, and PFAS testing.
The novus V55 mass spectrometer is built for real-world business scenarios and practical application value:
1. aeMRM (accelerated MRM): Capable of acquiring up to 1,000 MRMs per second, significantly improving sample throughput and expanding detection capabilities while maintaining quantitative accuracy.
2. The new SCIEX OS 5.0 software introduces several feature upgrades:
- Central Metrics Tracker: Enables continuous monitoring of system performance and method-level metrics.
- Central Monitoring: Provides a centralized view of the operational status of multiple instruments.
- Reporter Template Creator: Allows easy creation of customized reports.
- AI-powered helpme feature: Supports natural language interaction to quickly answer user questions about software features and functions.
- AI-powered Calculated Columns feature: Allows users to create custom calculations for data columns using natural language, further improving data processing efficiency.
3. The OptiFlow ion source is derived from a mature technology platform trusted by numerous users worldwide, continuing the consistent reliability and high sensitivity performance of the SCIEX system.
4. 35% reduction in floor space, making it one of the most compact triple quadrupole mass spectrometry systems in its class without sacrificing sensitivity or quantitative performance.
5. 40% reduction in both energy consumption and laboratory cooling requirements, effectively lowering laboratory operational energy costs.
6. Compatible with any LC system, supports LIMS, and complies with 21 CFR Part 11 requirements, helping laboratories ensure compliance and operational confidence while running efficiently.
Chris Lock, Vice President of Global R&D at SCIEX, stated: “Today, analytical laboratories need to deliver more valuable data insights in less time, with less space, and lower energy consumption. With the novus V55 mass spectrometer, SCIEX integrates decades of technological innovation into a next-generation platform, further enhancing performance and operational efficiency while ensuring system robustness and sensitivity. This next-generation mass spectrometry platform will help our customers advance their business more efficiently.”
The fifth-generation quantitative mass spectrometry platform, the novus V55 mass spectrometer, builds on SCIEX’s deep and mature expertise in quantitative mass spectrometry. In 1981, SCIEX launched the TAGA 6000, the first commercial triple quadrupole mass spectrometry system. Since then, SCIEX’s triple quadrupole mass spectrometry technology has continuously evolved, from the API III and API 3000 to the SCIEX Triple Quad series, represented by the SCIEX Triple Quad 5500. Additionally, SCIEX pioneered the QTRAP technology, achieving an innovative fusion of triple quadrupole and linear ion trap, opening up new possibilities for expanding quantitative and characterization analysis performance.
About SCIEX
SCIEX is dedicated to providing solutions for precise detection and compound quantification, helping our customers protect and improve human health and safety. We have over 50 years of innovation experience in mass spectrometry technology. Since successfully launching the first commercial SCIEX triple quadrupole mass spectrometry system in 1981, we have been committed to developing breakthrough technologies and solutions that influence and advance scientific research and outcomes that improve people’s lives.
Today, as part of Danaher Corporation (NYSE: DHR), a global life sciences and technology innovator, we continue to develop robust solutions in mass spectrometry and capillary electrophoresis technology. We help customers monitor environmental hazards and respond quickly; better understand diseases and disease markers, improve clinical treatment of diseases, and support the development and approval of related drugs; and ensure food is healthier and safer.